COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL) from its SEC filings: 2025 revenue $780.6 million (+24% vs the year before), net margin 8%, free cash flow $327.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $780.6 million |
| Revenue growth | +24% |
| Net income | $63.0 million |
| Net margin | 8.1% |
| Free cash flow | $327.6 million |
| Diluted EPS | $1.73 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +6% |
| Cash | $129.5 million |
| Long-term debt | $11.5 million |
| Share count, 1 year | +3% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.